Australia COPD Drugs Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4187

  • Format: PPT, PDF

Australian COPD Drugs Market: Segmented by Type (Chronic bronchitis, & Emphysema), by Drug Class (Short-acting bronchodilators, Corticosteroids, Methylxanthines, Long-acting bronchodilators, Combination drugs, Roflumilast, Mucoactive drugs, Vaccines, & Others)- Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The Australian COPD Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In 2014 COPD was the fifth leading cause of death in Australia. In that year 7,025 people died from COPD (4.6% of all deaths). One of the best ways Australians can prevent COPD is to avoid smoking or stop smoking if already a smoker. Several new COPD inhalers have been released into the Australian market in recent years to help people manage their condition. The new NPS MedicineWise educational program will help consumers and health professionals select inhaler medicines that best match individual needs, and this drive the growth of the Australian COPD market in the forecasted period.

Market Drivers

Certain factors that are driving the market growth include an increase in incidence and prevalence of COPD, an increased number of smokers, and a growing geriatric population.

The Australian population is aging, with older Australians a growing proportion of the total population. In 2017, 15% of Australians (3.8 million) were aged 65 and over; this proportion is projected to grow steadily over the coming decades. Over 1 in 7 Australians are aged 65 and over, around half of the older Australians aged 665 and aver are women, & 3 in 10 older Australians aged 65 and over were born overseas.

In Australia, the main cause of COPD is smoking however COPD can occur in people who have never smoked a cigarette in their lives. Exposure to passive smoke, outdoor air pollution, occupational chemicals, and dust are other known risk factors. Men and women smoked a similar number of cigarettes per day in 2019—an average of 13.1 and 12.9 cigarettes per day respectively in Australia.


The development of COPD occurs over many years and therefore affects mainly middle-aged and older people. The prevalence of COPD increases with age, mostly occurring in people aged 45 and over.

In the 2017–18 ABS National Health Survey (NHS), the prevalence of COPD (captured here as self-reported emphysema and/or bronchitis) in Australians aged 45 and over was 4.8%, or an estimated 464,000 people (ABS 2018). Overall, the prevalence did not differ significantly between men and women (4.5% and 5.1% respectively) however, for those aged 55–64, COPD was more prevalent in women compared with men (6.2% and 3.6%, respectively).


1. Australian COPD Drugs Market Overview…………………………………
A. Market Size
2. Market Growth Drivers…………………………………………….……………………….
A. Increase in Incidence and Prevalence of COPD
B. Growing Geriatric Population
C. Increased Number of Smokers
3. Epidemiology……………………………………………………….…
A. Prevalence of COPD by Sex and Age Group
4. COPD Market Segmentation…………………………………………
A. Type
I. Chronic Bronchitis
II. Emphysema
B. Drug Class
I. Short-Acting Bronchodilators
II. Corticosteroids
III. Methylxanthines
IV. Long-Acting Bronchodilators
V. Combination Drugs
VI. Roflumilast
VII. Mucoactive Drugs
VIII. Vaccines
IX. Others
5. COPD Drugs Major Products Market Share…………………….…………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape……………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Abbott Laboratories overview, Product & Services, Strategies & Financials
B. Novartis AG overview, Product & Services, Strategies & Financials
C. Teva Pharmaceutical Company overview, Product & Services, Strategies & Financials
D. GlaxoSmithKline Plc Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of COPD Drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Type:

COPD (which includes chronic bronchitis and emphysema) is a common disease in Australia and a major cause of disability, hospital admissions, and mortality. It is ranked third in the overall burden of disease after heart disease and stroke. More than half a million Australians are estimated to suffer from moderate to severe disease, and COPD ranks fourth among the common causes of death in Australian men, and sixth in women. Rates are even significantly higher in the Australian Aboriginal population.

Chronic bronchitis is common among smokers. In Western countries, it is estimated that chronic bronchitis occurs in approximately 18% of male and 14% of female smokers compared to 7% and 6% of non-smokers, respectively.

By Drug Class:

Based on the Drug Class the market is segmented into Short-acting bronchodilators: help open your airways to make breathing easier, Corticosteroids: reduces inflammation in the body, making airflow easier in the lungs, Methylxanthines: anti-inflammatory drug and relaxes the muscles in the airways, Long-acting bronchodilators:  help ease breathing, they don’t act as quickly as rescue medication, Combination drugs: recommended for those who continue to have shortness of breath or trouble breathing and are currently using LABA and LAMA combination therapy, Roflumilast: helps relieve inflammation, which can improve airflow to your lungs, Mucoactive drugs: help reduce mucus or thin it so you can more easily cough it up, Vaccines: reduce your risk for getting sick and can help you avoid infections and other complications related to COPD, & Others.

Major Players

The industry is competitive in nature with key players involved in mergers & acquisitions, new product development, collaborations & partnerships, and expansion strategies to augment market penetration. The key players in the COPD market are AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Abbott Laboratories, & Teva Pharmaceutical.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements